Möchten Sie immer auf dem neuesten Stand bleiben?

Hyderabad, India, May 06, 2026 (GLOBE NEWSWIRE) -- According to the latest report by Mordor Intelligence, the healthcare supply chain management market size is projected to grow from USD 3.94...

~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on...

Same-restaurant sales growth of 2.8%Total revenues increased 17.3%Net loss of $(2.7) million and Adjusted EBITDA of $27.8 million16 new system-wide restaurants opened in 11 states BRADENTON, Fla.,...

Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients...

Hangzhou, China, May 01, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its...

Quarterly revenue of $303 million - Softer than expected demand, particularly in our Truck Body business, led to revenue coming in below our guidance range. Parts & Services generated...

Net income: $125 million, $163 million excluding identified items1Diluted earnings per share: $0.38 per share; $0.49 per share excluding identified itemsEBITDA: $568 million, $615 million excluding...

ROTTERDAM, Netherlands, May 01, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced that it has successfully completed the sale of select European olefins and polyolefins assets, and...

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Supplier Audits & Vendor Qualification Training: Avoid FDA 483s and Ensure GMP Compliance (July 14th - July 16th, 2026)" training has been added...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD® U.S. net sales increased 52%...